World's Best Scientists 2026 revealed!
Jan C. Buckner

Jan C. Buckner

D-Index & Metrics

Medicine

D-Index
95
Citations
34706
World Ranking
10032
National Ranking
5166

Overview

Jan C. Buckner is affiliated with the Mayo Clinic in the United States and has contributed extensively to research in Medicine, with a focus on Genetics, Pulmonary and Respiratory Medicine, and Oncology. Their scholarly output includes a significant number of publications related to glioma diagnosis and treatment, brain metastases, health systems and economic evaluations, as well as advanced radiotherapy techniques and immunotherapy.

The scientist's research covers several main topics:

  • Glioma Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Advanced Radiotherapy Techniques
  • Biomedical Ethics and Regulation
  • Ethics in Clinical Research
  • Immunotherapy and Immune Responses

Jan C. Buckner's recent published papers include:

  • "Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma," 2020, Journal of Clinical Oncology
  • "Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis," 2022, JAMA Oncology
  • "Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma," 2020, Neuro-Oncology
  • "Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial," 2024, Nature Communications
  • "Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development," 2020, Expert Review of Anticancer Therapy

The frequent co-authors with whom Jan C. Buckner has collaborated include:

  • Jon C. Tilburt
  • Paul D. Brown
  • S. Keith Anderson
  • Evanthia Galanis
  • Minesh P. Mehta

Publications predominantly appear in some of the following scientific venues:

  • Journal of Clinical Oncology
  • Neuro-Oncology
  • Neuro-Oncology Advances
  • International Journal of Radiation Oncology*Biology*Physics
  • JAMA Oncology

Their work broadly spans the subfields of Genetics, Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, and General Health Professions, reflecting a multidisciplinary approach within medical research.

Best Publications

  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

    Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh

  • Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

    Paul D. Brown;Kurt Jaeckle;Karla V. Ballman;Elana Farace

  • Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

    Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins

  • Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson

  • Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Jan C. Buckner;Edward G. Shaw;Stephanie L. Pugh;Arnab Chakravarti

  • A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    Robert B. Jenkins;Hilary Blair;Karla V. Ballman;Caterina Giannini

  • Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

    Gregory Cairncross;B. Berkey;Edward G. Shaw;Robert Brian Jenkins

  • Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Jan C. Buckner;Matthew J. Maurer;Jeffrey I. Kreisberg

  • PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

    Justin S. Smith;Issei Tachibana;Sandra M. Passe;Brenda K. Huntley

  • RANDOMIZED COMPARISON OF STEREOTACTIC RADIOSURGERY FOLLOWED BY CONVENTIONAL RADIOTHERAPY WITH CARMUSTINE TO CONVENTIONAL RADIOTHERAPY WITH CARMUSTINE FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME: REPORT OF RADIATION THERAPY ONCOLOGY GROUP 93-05 PROTOCOL

    Luis Souhami;Wendy Seiferheld;David Brachman;Ervin B. Podgorsak

  • Factors influencing survival in high-grade gliomas

    Jan C Buckner

  • Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility

    Margaret Wrensch;Robert B. Jenkins;Jeffrey S. Chang;Ru Fang Yeh

  • Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

    Jann N Sarkaria;Leland S Hu;Ian F Parney;Deanna H Pafundi

  • Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

    G Cairncross;D Macdonald;S Ludwin;D Lee

  • Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

    J. Gregory Cairncross;Meihua Wang;Robert B. Jenkins;Edward G. Shaw

  • Central Nervous System Tumors

    Jan C Buckner;Paul D Brown;Brian P O'Neill;Frederic B Meyer

  • The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

    Karla V. Ballman;Jan C. Buckner;Paul D. Brown;Caterina Giannini

  • Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Kurt A. Jaeckle;Matthew J. Maurer;Joel M. Reid

  • Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma

    Christopher E. Pelloski;Karla V. Ballman;Alfred F. Furth;Li Zhang

  • Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

    Edward G. Shaw;Meihua Wang;Stephen W. Coons;David G. Brachman

Frequent Co-Authors

Paul D. Brown
Paul D. Brown Mayo Clinic
Evanthia Galanis
Evanthia Galanis Mayo Clinic
Karla V. Ballman
Karla V. Ballman Cornell University
Minesh P. Mehta
Minesh P. Mehta University of Maryland, Baltimore
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Walter J. Curran
Walter J. Curran Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering Medicine in the USA, there are several alternative online degrees and career pathways that can help accelerate or broaden your healthcare career. One popular choice is pursuing fast track lpn programs, allowing you to become a Licensed Practical Nurse faster than traditional routes.

Mental health is another growing field. Nurses can advance their qualifications and meet critical needs through fast track mental health nursing programs available online. These programs prepare you to support patients with psychiatric disorders in a clinical setting.

If you are more interested in the business side of healthcare, an healthcare administration degree online provides flexible options to launch or grow your management career. For advanced leadership roles, consider exploring affordable mha online programs to obtain your Master’s in Healthcare Administration at a lower cost.

These online options offer flexibility and diverse opportunities for anyone aiming to enter or progress within the healthcare sector.

Best Scientists Citing Jan C. Buckner

Trending Scientists